Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$58.76 - $75.07 $72,216 - $92,261
-1,229 Reduced 29.32%
2,962 $214,000
Q4 2023

Feb 07, 2024

SELL
$57.0 - $61.94 $47,880 - $52,029
-840 Reduced 16.7%
4,191 $256,000
Q3 2023

Oct 31, 2023

SELL
$56.7 - $68.29 $5,783 - $6,965
-102 Reduced 1.99%
5,031 $287,000
Q2 2023

Aug 08, 2023

SELL
$56.28 - $63.76 $37,989 - $43,038
-675 Reduced 11.62%
5,133 $305,000
Q1 2023

May 10, 2023

SELL
$58.41 - $67.05 $4,380 - $5,028
-75 Reduced 1.27%
5,808 $363,000
Q4 2022

Feb 09, 2023

BUY
$49.75 - $63.89 $24,725 - $31,753
497 Added 9.23%
5,883 $368,000
Q3 2022

Nov 14, 2022

BUY
$48.72 - $61.12 $14,664 - $18,397
301 Added 5.92%
5,386 $268,000
Q2 2022

Aug 15, 2022

BUY
$52.06 - $58.9 $264,725 - $299,506
5,085 New
5,085 $299,000

Others Institutions Holding PBH

About Prestige Consumer Healthcare Inc.


  • Ticker PBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,762,600
  • Market Cap $3.77B
  • Description
  • Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...
More about PBH
Track This Portfolio

Track Vise Technologies, Inc. Portfolio

Follow Vise Technologies, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vise Technologies, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vise Technologies, Inc. with notifications on news.